IS7320A - Peptíð ætluð til meðhöndlunar á krabbameini tengdu þekjuæxlisveiru (HPV) í manni og öðrum þekjuvefsæxlum - Google Patents

Peptíð ætluð til meðhöndlunar á krabbameini tengdu þekjuæxlisveiru (HPV) í manni og öðrum þekjuvefsæxlum

Info

Publication number: IS7320A
Authority: IS; Iceland
Prior art keywords: epithelial; hpv; cancer; treatment; human carcinoma
Prior art date: 2001-12-20

Application number

IS7320A

Other languages

English (en)

Other versions

IS2906B (is

Inventor

Gonzalez Barrios Belkis

Puchades Izaguirre Yaquelin

Santos Savio Alicia

Silva Rodriguez Ricardo

Javier Gonzalez Lopez Luis

Moro Soria Alejandro

Ernesto Perea Rodriguez Silvio

Reyes Acosta Osvaldo

Francisco Santiago Vispo Nelson

Original Assignee

Centro De Ingenieria Genetica Y Biotechnologia

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-12-20

Filing date

2004-06-16

Publication date

2004-06-16

2004-06-16 Application filed by Centro De Ingenieria Genetica Y Biotechnologia filed Critical Centro De Ingenieria Genetica Y Biotechnologia

2004-06-16 Publication of IS7320A publication Critical patent/IS7320A/is

2014-11-15 Publication of IS2906B publication Critical patent/IS2906B/is

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/005—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/10—Fusion polypeptide containing a localisation/targetting motif containing a tag for extracellular membrane crossing, e.g. TAT or VP22
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20032—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Genetics & Genomics (AREA)
Engineering & Computer Science (AREA)
Biochemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Zoology (AREA)
Molecular Biology (AREA)
Virology (AREA)
Wood Science & Technology (AREA)
Biophysics (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Biotechnology (AREA)
Epidemiology (AREA)
Biomedical Technology (AREA)
Microbiology (AREA)
General Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)

IS7320A 2001-12-20 2004-06-16 Peptíð til meðhöndlunar á krabbameini sem tengist vörtuveiru manna (HPV) og önnur þekjuæxli IS2906B (is)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
CU20010309A CU23225A1 (es)	2001-12-20	2001-12-20	PéPTIDOS PARA EL TRATAMIENTO DEL CáNCER ASOCIADO AL VIRUS PAPILOMA HUMANO (VPH) Y DE OTROS TUMORES EPITELIALES
PCT/CU2002/000010 WO2003054002A1 (es)	2001-12-20	2002-12-04	Péptidos para el tratamiento del cáncer asociado al virus papiloma humano (vph) y de otros tumores epiteliales

Publications (2)

Publication Number	Publication Date
IS7320A true IS7320A (is)	2004-06-16
IS2906B IS2906B (is)	2014-11-15

Family

ID=40091679

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IS7320A IS2906B (is)	2001-12-20	2004-06-16	Peptíð til meðhöndlunar á krabbameini sem tengist vörtuveiru manna (HPV) og önnur þekjuæxli

Country Status (33)

Country	Link
US (2)	US7374767B2 (is)
EP (2)	EP1491553B1 (is)
JP (1)	JP4056476B2 (is)
KR (1)	KR100642437B1 (is)
CN (1)	CN100368431C (is)
AR (1)	AR037825A1 (is)
AT (1)	ATE520704T1 (is)
AU (1)	AU2002361922B2 (is)
BR (1)	BRPI0215213C1 (is)
CA (1)	CA2471110C (is)
CR (1)	CR7361A (is)
CU (1)	CU23225A1 (is)
DK (1)	DK1491553T3 (is)
DO (1)	DOP2002000548A (is)
ES (1)	ES2371239T3 (is)
HN (1)	HN2002000377A (is)
HR (1)	HRP20040663B1 (is)
IL (2)	IL162633A0 (is)
IS (1)	IS2906B (is)
MA (1)	MA27868A1 (is)
MX (1)	MXPA04005832A (is)
MY (1)	MY133530A (is)
NO (1)	NO333259B1 (is)
NZ (1)	NZ534170A (is)
PE (1)	PE20030861A1 (is)
PT (1)	PT1491553E (is)
RU (1)	RU2290410C2 (is)
SI (1)	SI1491553T1 (is)
TN (1)	TNSN04114A1 (is)
UA (1)	UA81403C2 (is)
UY (1)	UY27602A1 (is)
WO (1)	WO2003054002A1 (is)
ZA (1)	ZA200405514B (is)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CU23225A1 (es) *	2001-12-20	2007-08-30	Ct Ingenieria Genetica Biotech	PéPTIDOS PARA EL TRATAMIENTO DEL CáNCER ASOCIADO AL VIRUS PAPILOMA HUMANO (VPH) Y DE OTROS TUMORES EPITELIALES
CU23431B6 (es) *	2005-05-12	2009-10-16	Ct Ingenieria Genetica Biotech	Método para la inhibición de la proliferación de células tumorales y el tratamiento del cáncer
GB2433740A (en)	2005-12-23	2007-07-04	Rapid Biosensor Systems Ltd	Detection of tuberculosis infection
CU23511B6 (es) *	2006-02-28	2010-04-13	Biorec B V	Combinación farmacéutica para el tratamiento y/o quimiosensibilización de tumores refractarios a drogas anticancerígenas
GB2441131A (en) *	2006-08-24	2008-02-27	Univ Dundee	Modulation of binding of CK2a to NDPK
CN100522992C (zh) *	2007-02-12	2009-08-05	中国科学院昆明动物研究所	一种环状小肽ba
US20110052725A1 (en) *	2007-03-27	2011-03-03	Takashi Shibata	Therapeutic agent for infectious skin and mucosal disease
US20110305706A1 (en)	2009-02-23	2011-12-15	Scott Thomas Brady	Compositions and Methods for Treating a Disease Mediated by Soluble Oligomeric Amyloid Beta
EP2406379A4 (en) *	2009-03-13	2012-09-26	Egen Inc	COMPOSITIONS AND METHODS FOR RELEASING BIOLOGICALLY ACTIVE RNA
CN108712911A (zh)	2015-12-30	2018-10-26	科达制药股份有限公司	抗体及其缀合物
CU20200103A7 (es) *	2020-12-18	2022-07-08	Ct Ingenieria Genetica Biotecnologia	Péptido sintético para la inducción de inmunidad antitumoral y antiviral
CU24766B1 (es)	2021-07-09	2025-08-13	Ct Ingenieria Genetica Biotecnologia	Péptidos lineales que inhiben la fosforilación mediada por ck2
CN118370805B (zh) *	2024-04-29	2025-02-14	广州中科佰氏健康产业有限公司	一种抑菌妇科凝胶及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IE902820A1 (en)	1989-08-07	1991-02-27	Merck & Co Inc	Peptide inhibitors of human papilloma virus protein binding¹to retinoblastoma gene proteins
JPH05310784A (ja) *	1991-09-04	1993-11-22	Merck & Co Inc	ヒト乳頭腫ウイルスタンパク質と網膜芽細胞腫遺伝子タンパク質との結合のペプチド阻害剤
GB9313556D0 (en) *	1993-07-01	1993-08-18	British Tech Group	Synthetic peptides of human papillomavirus
US5625031A (en) *	1994-02-08	1997-04-29	Bristol-Myers Squibb Company	Peptide inhibitors of the p33cdk2 and p34cdc2 cell cycle regulatory kinases and human papillomavirus E7 oncoprotein
ATE235509T1 (de)	1998-06-30	2003-04-15	Deutsches Krebsforsch	Peptide zur inhibition von hpv e7 proteinen
US6641994B2 (en)	1999-08-25	2003-11-04	Pharmacia & Upjohn Company	Methods of identifying anti-viral agents
AU2001238347A1 (en) *	2000-02-28	2001-09-12	Hyseq, Inc.	Novel nucleic acids and polypeptides
CU23225A1 (es) *	2001-12-20	2007-08-30	Ct Ingenieria Genetica Biotech	PéPTIDOS PARA EL TRATAMIENTO DEL CáNCER ASOCIADO AL VIRUS PAPILOMA HUMANO (VPH) Y DE OTROS TUMORES EPITELIALES

2001
- 2001-12-20 CU CU20010309A patent/CU23225A1/es unknown
2002
- 2002-04-12 UA UA20040705927A patent/UA81403C2/uk unknown
- 2002-12-04 CN CNB028282698A patent/CN100368431C/zh not_active Expired - Lifetime
- 2002-12-04 US US10/499,458 patent/US7374767B2/en not_active Expired - Lifetime
- 2002-12-04 WO PCT/CU2002/000010 patent/WO2003054002A1/es not_active Ceased
- 2002-12-04 IL IL16263302A patent/IL162633A0/xx active IP Right Grant
- 2002-12-04 AU AU2002361922A patent/AU2002361922B2/en not_active Ceased
- 2002-12-04 EP EP02796490A patent/EP1491553B1/en not_active Expired - Lifetime
- 2002-12-04 SI SI200230967T patent/SI1491553T1/sl unknown
- 2002-12-04 CA CA2471110A patent/CA2471110C/en not_active Expired - Lifetime
- 2002-12-04 DK DK02796490.7T patent/DK1491553T3/da active
- 2002-12-04 ES ES02796490T patent/ES2371239T3/es not_active Expired - Lifetime
- 2002-12-04 PT PT02796490T patent/PT1491553E/pt unknown
- 2002-12-04 EP EP11168526A patent/EP2383282A1/en not_active Ceased
- 2002-12-04 NZ NZ534170A patent/NZ534170A/en not_active IP Right Cessation
- 2002-12-04 BR BRPI0215213A patent/BRPI0215213C1/pt not_active IP Right Cessation
- 2002-12-04 KR KR1020047009771A patent/KR100642437B1/ko not_active Expired - Fee Related
- 2002-12-04 RU RU2004122084/13A patent/RU2290410C2/ru active
- 2002-12-04 HR HRP20040663AA patent/HRP20040663B1/hr not_active IP Right Cessation
- 2002-12-04 MX MXPA04005832A patent/MXPA04005832A/es active IP Right Grant
- 2002-12-04 JP JP2003554718A patent/JP4056476B2/ja not_active Expired - Fee Related
- 2002-12-04 AT AT02796490T patent/ATE520704T1/de active
- 2002-12-11 MY MYPI20024638A patent/MY133530A/en unknown
- 2002-12-13 AR ARP020104844A patent/AR037825A1/es not_active Application Discontinuation
- 2002-12-17 DO DO2002000548A patent/DOP2002000548A/es unknown
- 2002-12-19 HN HN2002000377A patent/HN2002000377A/es unknown
- 2002-12-20 UY UY27602A patent/UY27602A1/es active IP Right Grant
2003
- 2003-01-06 PE PE2003000006A patent/PE20030861A1/es not_active Application Discontinuation
2004
- 2004-06-04 CR CR7361A patent/CR7361A/es unknown
- 2004-06-15 MA MA27740A patent/MA27868A1/fr unknown
- 2004-06-16 IS IS7320A patent/IS2906B/is unknown
- 2004-06-17 TN TNP2004000114A patent/TNSN04114A1/en unknown
- 2004-06-20 IL IL162633A patent/IL162633A/en not_active IP Right Cessation
- 2004-07-12 ZA ZA2004/05514A patent/ZA200405514B/en unknown
- 2004-07-20 NO NO20043112A patent/NO333259B1/no not_active IP Right Cessation
2008
- 2008-04-08 US US12/099,646 patent/US7947287B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
CA2471110A1 (en)	2003-07-03
NO20043112L (no)	2004-07-20
NZ534170A (en)	2006-08-31
CU23225A1 (es)	2007-08-30
ES2371239T3 (es)	2011-12-28
IS2906B (is)	2014-11-15
BRPI0215213C1 (pt)	2021-05-25
EP1491553A1 (en)	2004-12-29
US7374767B2 (en)	2008-05-20
PT1491553E (pt)	2011-11-25
HN2002000377A (es)	2003-04-10
MY133530A (en)	2007-11-30
SI1491553T1 (sl)	2011-12-30
KR20050002811A (ko)	2005-01-10
CN100368431C (zh)	2008-02-13
IL162633A (en)	2011-02-28
WO2003054002A1 (es)	2003-07-03
JP4056476B2 (ja)	2008-03-05
TNSN04114A1 (en)	2006-06-01
AR037825A1 (es)	2004-12-09
HRP20040663A2 (en)	2005-08-31
BRPI0215213B1 (pt)	2018-09-11
CR7361A (es)	2005-02-18
EP2383282A1 (en)	2011-11-02
HRP20040663B1 (hr)	2013-05-31
US7947287B2 (en)	2011-05-24
IL162633A0 (is)	2005-11-20
MXPA04005832A (es)	2004-09-13
UY27602A1 (es)	2003-04-30
HK1068901A1 (en)	2005-05-06
AU2002361922A1 (en)	2003-07-09
ZA200405514B (en)	2005-03-30
JP2005525090A (ja)	2005-08-25
UA81403C2 (en)	2008-01-10
DOP2002000548A (es)	2003-06-30
ATE520704T1 (de)	2011-09-15
RU2290410C2 (ru)	2006-12-27
RU2004122084A (ru)	2005-03-27
DK1491553T3 (da)	2011-12-05
CN1620464A (zh)	2005-05-25
MA27868A1 (fr)	2006-05-02
US20090005294A1 (en)	2009-01-01
NO333259B1 (no)	2013-04-22
PE20030861A1 (es)	2003-12-02
US20060233742A1 (en)	2006-10-19
AU2002361922B2 (en)	2007-04-05
EP1491553B1 (en)	2011-08-17
KR100642437B1 (ko)	2006-11-06
CA2471110C (en)	2017-01-31
BR0215213A (pt)	2004-12-07

Publication	Publication Date	Title
IS6965A (is)	2003-09-23	Ganglíósíð-tengd raðbrigða mótefni og notkun þeirra í sjúkdómsgreiningu og meðferð á æxlum
IS2468B (is)	2008-12-15	Aðferðir og milliefni til framleiðslu á efnasamböndum gegn krabbameini
DK1446012T3 (da)	2013-10-14	Bakteriolytisk kombinationsterapi til behandling af tumorer
IL202332A0 (en)	2011-08-01	Liv-1 related protein, polynucleotides encoding the same and use thereof for treatment of cancer
KR100695846B9 (ko)	2021-09-30	암 치료
IS7137A (is)	2004-01-30	Samsett meðferð til meðhöndlunar á krabbameini
IS7320A (is)	2004-06-16	Peptíð ætluð til meðhöndlunar á krabbameini tengdu þekjuæxlisveiru (HPV) í manni og öðrum þekjuvefsæxlum
NO20052760D0 (no)	2005-06-07	Fremgangsmate for behandling av kreft og beslektede fremgangsmater.
IS6303A (is)	2002-03-18	Notkun retígabíns til meðhöndlunar á taugasjúkdómatengdum sársauka
NO20041216L (no)	2004-05-05	Imidazol-4-karboksamidderivater, fremstilling og anvendelse derav for behandling av overvekt
MY136095A (en)	2008-08-29	Use of human anti-ctla-4 antibodies for treatment of cancer
IS7691A (is)	2005-02-09	Lyfjasamsetningar til að meðhöndla æxli
NO20044192L (no)	2004-10-04	17alfa-alkyl-17beta-oksy-ostratriener og farmasoytiske preparater
NO20015516D0 (no)	2001-11-12	Preparater og anvendelser av ET743 for behandling av kreft
DK1567641T3 (da)	2012-08-27	Proaerolysin indeholdende proteaseaktiveringssekvenser og fremgangsmåder til anvendelse til behandling af prostatacancer.
AU2003219555A8 (en)	2003-10-20	Depsipeptide for therapy of kidney cancer
EP1550453A4 (en)	2009-06-24	PREPARATION OF CANCER ANTIGEN PEPTIDES
AU2003254641A8 (en)	2004-03-19	Interferon beta-like molecules for treatment of cancer
WO2003026494A3 (en)	2005-01-20	Galectins-1-and-4 in tumor development
DK1239862T3 (da)	2005-10-31	Farmaceutisk præparat indeholdende cytostatika og eletronacceptorer til behandling af kræft
IS6707A (is)	2003-02-03	Efnablanda til forvarna og meðhöndlunar á krabbameini
DK1496918T3 (da)	2023-05-15	Anvendelse af natriummetaarsenit til behandling af tumorer
AU2002346049A1 (en)	2003-01-21	Coactivators in the diagnosis and treatment of breast cancer
AU2002366195A8 (en)	2003-06-10	Use of bisindolmaleimide and gemcitabine for the treatment of cancer
HUP0400661A3 (en)	2008-03-28	Identification of specific tumor antigens by means of the selection os cdna libraries with sera and the use of said antigena in the treatment of tumors